13 unknown. 13 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 13 | Unknown 13 |
Follow Thromboembolism: new trials by email Literature Review of Thromboembolism trials Research Report on Thromboembolism
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TRanEXamic Acid to Decrease Heavy Menstrual Bleeding in Individuals Anticoagulated for Venous Thromboembolism Pilot Study Tranexamic acid, No Tranexamic acid - Venous Thromboembolism, Venous Thromboses | Phase 4 | Unknown | University Health Network, Toronto | 20 | 2024-06-01 | 2024-06-12 |
| Goal-directed vs Preemptive Tranexamic Acid Administration in Non-cardiac Surgery TXA, TEG6 - Arthritis Knee, Spine Fusion | Phase 4 | Unknown | Konkuk University Medical Center | 148 | 2024-02-10 | 2024-05-14 |
| Study of Low Molecular Weight Heparins Dalteparin Prefilled Syringe, Tinzaparin profiled syringe - Anticoagulant, Venous Thromboembolism | Phase 4 | Unknown | Herlev Hospital | 65000 | 2023-03-23 | 2023-08-31 |
| Thromboprophylaxis in Oesophageal Cancer Patients Fragmin 5000 UNT in 0.2 ML Prefilled Syringe - Esophageal Neoplasms, Thrombosis | Phase 4 | Unknown | University of Aarhus | 100 | 2021-05-01 | 2021-10-05 |
| Deep Vein Thrombosis Prophylaxis Adherence: Enoxaparin vs Rivaroxaban Enoxaparin 40 milligram/0.4 milliliter Injectable Syringe 0.4 milliliters, Rivaroxaban 10 milligram Oral Tablet - Deep Vein Thrombosis, Venous Thromboembolism | Phase 4 | Unknown | Florida Orthopaedic Institute | 128 | 2020-01-13 | 2020-01-18 |
| A Prospective Study in Chinese Patients With Lower Extremity Ankle Fracture of Oral Anticoagulants to Prevent Venous Thromboembolism (VTE) Apixaban Oral Tablet - Foot Ankle Injuries, Anticoagulants and Bleeding Disorders | Phase 4 | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 1000 | 2020-01-01 | 2019-11-19 |
| Comparision Between Activated Partial Thromboplastin Time Versus Anti-Xa Activity in Heparin Monitoring Unfractionated heparin - Myocardial Infarction, Venous Thromboembolism | Phase 4 | Unknown | Wuhan Asia Heart Hospital | 700 | 2018-03-01 | 2018-03-14 |
| Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD) Enoxaparin Sodium Injection 30 mg BID, Enoxaparin Sodium Injection 40 mg QD - Trauma, Surgery | Phase 4 | Unknown | Oregon Health and Science University | 606 | 2014-02-01 | 2024-04-03 |
| Weight Based Enoxaparin in Trauma Patients Dosing of enoxaparin for VTE prophylaxis - Venous Thromboembolism | Phase 4 | Unknown | Intermountain Health Care, Inc. | 1200 | 2013-07-01 | 2017-04-05 |
| Prophylaxis of Venous Thromboembolism After Bariatric Surgery Nadroparin - Morbid Obesity, Thromboembolism | Phase 4 | Unknown | Rijnstate Hospital | 50 | 2013-03-01 | 2014-11-20 |
| Incidence of Acute Cerebrovascular Events Using Either Minimized or Standard Cardiopulmonary Bypass Circuit ROCsafeTM - Coronary Artery Disease, Acute Cerebrovascular Accident | Phase 4 | Unknown | Hannover Medical School | 64 | 2009-04-01 | 2009-10-07 |
| Thromboprophylaxis and Bariatric Surgery Enoxaparin - Thromboembolism | Phase 4 | Unknown | University Hospital, Strasbourg, France | 300 | 2006-11-01 | 2012-07-02 |
| PC-Trial: Patent Foramen Ovale and Cryptogenic Embolism Percutaneous closure of patent foramen ovale, Medical antitrhombotic treatment - Embolism, Paradoxical, Heart Septal Defects, Atrial | Phase 4 | Unknown | Foundation for Cardiovascular Research, Zurich | 414 | 2000-02-01 | 2009-05-27 |
Venous Thromboembolism (6) · Venous Thrombosis (3) · Hemorrhage (2) · Hemostatic Disorders (2) · Stroke (2) · Wounds and Injuries (2) · Coronary Artery Disease (1) · Embolism, Air (1) · Embolism, Paradoxical (1) · Esophageal Neoplasms (1) · Foramen Ovale, Patent (1) · Heart Septal Defects, Atrial (1) · Intracranial Embolism (1) · Liver Neoplasms (1)
Cardiovascular Diseases (13) · Embolism and Thrombosis (13) · Vascular Diseases (13) · Pathological Conditions, Signs and Symptoms (4) · Heart Diseases (3) · Nervous System Diseases (3) · Pathologic Processes (3) · Thrombosis (3) · Brain Diseases (2) · Central Nervous System Diseases (2) · Cerebrovascular Disorders (2) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Genital Diseases (2)
Enoxaparin (3) · BID protein, human (1) · Heparin (1) · Heparin, Low-Molecular-Weight (1) · Nadroparin (1) · Rivaroxaban (1) · Tranexamic Acid (1) · apixaban (1) · enoxaparin sodium (1)
Florida Orthopaedic Institute (1) · Foundation for Cardiovascular Research, Zurich (1) · Hannover Medical School (1) · Herlev Hospital (1) · Intermountain Health Care, Inc. (1) · Konkuk University Medical Center (1) · Oregon Health and Science University (1) · Rijnstate Hospital (1) · Second Affiliated Hospital, Zhejiang University, School of Medicine (1) · University Health Network, Toronto (1) · University Hospital, Strasbourg, France (1) · University of Aarhus (1) · Wuhan Asia Heart Hospital (1)
United States (3) · China (2) · Denmark (2) · Australia (1) · Austria (1) · Belgium (1) · France (1) · Germany (1) · Netherlands (1) · South Korea (1) · Switzerland (1)
Anne-Mette Hvas, MD (1) · Annick Steib, MD (1) · Bernhard Meier, MD (1) · F.J. Berends, MD, PhD (1) · Hassan Mir, MD (1) · Ingo Kutschka, PD Dr. med. (1) · Martin A Schreiber, MD (1) · Tae-Yop Kim, MD, PhD (1)
PMID 21356042, PMID 23514285, PMID 36399673, PMID 36413425, PMID 39242497, PMID 40095681